Available EU DMF/CEP
EU DMF
CEP
API Status
Commercial
Pipeline
Therapeutic Category
Alimentary tract & metabolism
Anti-infectives for systemic use
Antipyretic, analgesic and anti-inflammatory
Antineoplastic & immunomodulating agents
Blood & blood forming organs
Cardiovascular system
Genito-urinary system & sex hormones
Injectable forms
Musculo-skeletal system
Nervous system
Opthalmological preparations
Respiratory system
Available US DMF
US DMF
Additional DMF
Japanese DMF
Chinese DMF
Korean DMF
Injectable Forms
Yes
No
Sort By
Alphabetical
Therapeutic Category
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
a
Apixaban

Therapeutic Area

Blood & blood forming organs

Polymorphic form

Crystalline form N-1

CAS No.

503612-47-3

Apremilast

Therapeutic Area

Musculo-skeletal system

Polymorphic form

Form B, Form N

CAS No.

608141-41-9

b
Baricitinib

Therapeutic Area

Antineoplastic & immunomodulating agents

Polymorphic form

Form I

CAS No.

1187594-09-7

Brexpiprazole

Therapeutic Area

Nervous system

Polymorphic form

Polymorphic form I

CAS No.

913611-97-9

d
Dabigatran etexilate mesylate

Therapeutic Area

Blood & blood forming organs

Polymorphic form

Form I

CAS No.

872728-81-9

Dapagliflozin

Therapeutic Area

Alimentary tract & metabolism

Polymorphic form

Amorphous

CAS No.

461432-26-8

Dapagliflozin propanediol monohydrate

Therapeutic Area

Alimentary tract & metabolism

Polymorphic form

Crystalline SC-3

CAS No.

960404-48-2

e
Empagliflozin

Therapeutic Area

Alimentary tract & metabolism

Polymorphic form

Crystalline anhydrous

CAS No.

864070-44-0

l
Linaclotide

Therapeutic Area

Alimentary tract & metabolism

Polymorphic form

Amorphous

CAS No.

851199-59-2

Linagliptin

Therapeutic Area

Alimentary tract & metabolism

Polymorphic form

Mix of form A & B

CAS No.

668270-12-0

o
Oxcarbazepine

Therapeutic Area

Nervous system

Polymorphic form

Form A

CAS No.

28721-07-5

p
Pimavanserin tartrate

Therapeutic Area

Nervous system

Polymorphic form

Crystalline anhydrous form C

CAS No.

706782-28-7 (tartrate)

r
Rivaroxaban

Therapeutic Area

Blood & blood forming organs

Polymorphic form

Modification I

CAS No.

366789-02-8

s
Sacubitril/Valsartan Complex

Therapeutic Area

Cardiovascular system

Polymorphic form

Crystalline

CAS No.

936623-90-4

Safinamide methanesulfonate

Therapeutic Area

Nervous system

Polymorphic form

Crystalline anhydrous modification A1

CAS No.

202825-46-5

Saxagliptin hydrochloride

Therapeutic Area

Alimentary tract & metabolism

Polymorphic form

H2-1 (HCl*2H2O)

CAS No.

709031-78-7

Saxagliptin monohydrate base

Therapeutic Area

Alimentary tract & metabolism

Polymorphic form

Orthorhombic Form H-1

CAS No.

361442-04-8

t
Ticagrelor

Therapeutic Area

Blood & blood forming organs

Polymorphic form

Form II

CAS No.

274693-27-5

DISCLAIMER
The above list is presented solely for informational purposes and does not constitute an offer in any sense. Products with PIPELINE & EARLY DEVELOPMENT STATUS under patent (SPC) protection in Poland and/or other countries are not offered until expiration of the corresponding IP right.

Products with COMMERCIAL STATUS are offered for commercial sale only in countries where the corresponding patents or SPCs expired. In case of the countries where the products are protected by valid patents or SPCs in force they are listed only for purposes reasonably related to conducting research, development and regulatory procedures provided for by Bolar-type exemption in the target country. It is within the partner´s responsibility and liability to check the patent situation of the product in the target market(s).

OK